Search Results - "Sibai, B. M."

First‐trimester screening with combined maternal clinical factors, biophysical and biomarkers to predict preterm pre‐eclampsia and hypertensive disorders: are they ready for clinical use? by Sibai, BM

Get full text

The benefits/risks of treatment of non‐severe hypertension in pregnancy and choice of drug remain unanswered by Sibai, BM

Get full text

Subfertility/infertility and assisted reproductive conception are independent risk factors for pre‐eclampsia by Sibai, BM

Get full text

Uterine balloon tamponade for the management of postpartum haemorrhage: a challenge and an opportunity for better evidence by Viteri, OA, Sibai, BM

Get full text

An aspirin a day in pregnancy keeps childhood hypertension away? by Parchem, JG, Sibai, BM

Get full text

Etiology and pathogenesis of preeclampsia: Current concepts by Dekker, Gustaaf A., Sibai, Baha M.

“…The etiology of preeclampsia is unknown. At present, 4 hypotheses are the subject of extensive investigation, as follows: (1) Placental ischemia—Increased…”
Get full text

The relationship between delivery and the PaO2/FiO2 ratio in COVID‐19: a cohort study by Pineles, BL, Stephens, A, Narendran, LM, Tigner, MA, Leidlein, C, Pedroza, C, Mendez‐Figueroa, H, Sibai, BM

“…Objective To study the effect of delivery on the pO2/FiO2 ratio (P/F ratio) in patients with COVID‐19‐related acute respiratory distress syndrome (ARDS) and to…”
Get full text

Prevention of preeclampsia: A big disappointment by Sibai, Baha M.

“…Preeclampsia is a multisystem disorder of unknown etiology. During the past 2 decades, numerous clinical reports and randomized trials described the use of…”
Get full text

Eclampsia. VIII. Risk factors for maternal morbidity by MATTAR, F, SIBAI, B. M

“…This study was undertaken to identify risk factors associated with adverse maternal outcome in pregnancies complicated by eclampsia. This was a descriptive…”
Get full text

Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome by Audibert, François, Friedman, Steven A., Frangieh, Antoine Y., Sibai, Baha M.

“…OBJECTIVE: Our purpose was to compare the maternal outcome of pregnancies complicated by HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome,…”
Get full text

An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue by Romero, Roberto, Sibai, Baha M., Sanchez-Ramos, Luis, Valenzuela, Guillermo J., Veille, Jean-Claude, Tabor, Bannie, Perry, Kenneth G., Varner, Michael, Goodwin, T.Murphy, Lane, Rosanne, Smith, Judith, Shangold, Gary, Creasy, George W.

“…Objectives: This study was designed to evaluate the efficacy and safety of the oxytocin receptor antagonist atosiban in the treatment of preterm labor. Study…”
Get full text

The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement from the ISSHP by Tranquilli, A.L, Dekker, G, Magee, L, Roberts, J, Sibai, B.M, Steyn, W, Zeeman, G.G, Brown, M.A

Get full text

Risk factors associated with preeclampsia in healthy nulliparous women by Sibai, B.M., Ewell, M., Levine, R.J., Klebanoff, M.A., Esterlitz, J., Catalano, P.M., Goldenberg, R.L., Joffe, G.

“…Objective: Our goal was to identify risk factors for the development of preeclampsia in nulliparous women enrolled in a multicenter trial comparing calcium…”
Get full text

OP08.02: Rates of pre‐eclampsia and gestational hypertension in placenta accreta versus gestational age and BMI matched controls: a case control study by Agarwal, N., Hernandez‐Andrade, E., Backley, S., Bergh, E., Espinoza, J., Salazar, A., Soto, E., Sibai, B. M., Papanna, R.

Get full text

Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: Does the HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome matter? by Abramovici, Dorel, Friedman, Steven A., Mercer, Brian M., Audibert, François, Kao, Lu, Sibai, Baha M.

“…Objective: Our purpose was to compare neonatal outcome after preterm delivery of infants whose gestation was complicated by the HELLP (hemolysis, elevated…”
Get full text

Trial of calcium to prevent preeclampsia by Levine, R.J, Hauth, J.C, Curet, L.B, Sibai, B.M, Catalano, P.M, Morris, C.D, DerSimonian, R, Esterlitz, J.R, Raymond, E.G, Bild, D.E

“…Background. Previous trials have suggested that calcium supplementation during pregnancy may reduce the risk of preeclampsia. However, differences in study…”
Get full text

OP05.09: Patients with placenta accreta spectrum have increased estimated fetal and birthweight by Agarwal, N., Hernandez‐Andrade, E., Lai, D., Backley, S., Bergh, E., Espinoza, J., Salazar, A., Soto, E., Sibai, B. M., Papanna, R.

Get full text

Magnesium sulfate therapy in preeclampsia and eclampsia by Witlin, AndreaG, Sibai, BahaM

“…Objective: To review the available evidence regarding efficacy, benefits, and risks of magnesium sulfate seizure prophylaxis in women with preeclampsia or…”
Get full text

Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation by Witlin, Andrea G, Saade, George R., Mattar, Farid, Sibai, Baha M

“…We sought to characterize predictors of neonatal outcome in women with severe preeclampsia or eclampsia who were delivered of their infants preterm. We…”
Get full text

Treatment of hypertensive complications in pregnancy by Coppage, K H, Sibai, B M

“…Hypertension is the most common medical disorder during pregnancy. Approximately 70 percent of women diagnosed with hypertension during pregnancy will have…”
Get more information